A chiral fluorescent Ir( iii ) complex that targets the GPX4 and ErbB pathways to induce cellular ferroptosis

Abstract excerpt

Ferroptosis has recently emerged as a non-apoptotic form of programmed cell death and promising target for anticancer treatment. However, it is challenging to discover ferroptosis inducers with both highly selective tumour targeting and low cytotoxicity to normal cells. Here, we report an Ir(iii) complex, Ir1, that contains a novel chiral pyridine RAS-selective lethal ligand (Py-RSL). This complex effectively...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Transport and Resistance Mechanisms
• Share to Ferroptosis and cancer prognosis
• Share to Peptidase Inhibition and Analysis